HTDS (Hard to Treat Diseases) Capex-to-Revenue : 0.00 (As of . 20)

Hard to Treat Diseases Capex-to-Revenue Chart

Competitive Comparison of Hard to Treat Diseases's Capex-to-Revenue

For the Biotechnology subindustry, Hard to Treat Diseases's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hard to Treat Diseases's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's Capex-to-Revenue falls into.

Hard to Treat Diseases Capex-to-Revenue Calculation

Hard to Treat Diseases's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Hard to Treat Diseases's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hard to Treat Diseases  (OTCPK:HTDS) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Hard to Treat Diseases Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases Business Description